Sulphadimidine, co-trimoxazole, and a placebo in the management of symptomatic urinary tract infection in general practice.
D000328:Adult; D000890:Anti-Infective Agents / Q000627:therapeutic use*; D001437:Bacteriuria / Q000188:drug therapy; D002986:Clinical Trials as Topic; D004338:Drug Combinations; D004352:Drug Resistance, Microbial; D005260:Female; D005493:Folic Acid Antagonists / Q000627:therapeutic use*; D006801:Humans; D010919:Placebos; D011743:Pyrimidines / Q000627:therapeutic use*; D013418:Sulfamethazine / Q000009:adverse effects / Q000627:therapeutic use*; D013420:Sulfamethoxazole / Q000627:therapeutic use*; D014295:Trimethoprim / Q000627:therapeutic use; D014552:Urinary Tract Infections / Q000188:drug therapy*
D000890:Anti-Infective Agents; D004338:Drug Combinations; D005493:Folic Acid Antagonists; D010919:Placebos; D011743:Pyrimidines; D013418:Sulfamethazine; D014295:Trimethoprim; D013420:Sulfamethoxazole